Advanced search
Most relevant results are first | Show most recent results first | Show use by person

Search only John DeasySearch all speeches

Results 4,501-4,520 of 5,388 for speaker:John Deasy

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: The Chairman raised speech and language issues earlier. Many people who are on the speech and language therapists' staff panel recently received an e-mail informing them that the existing panels would no longer be used to fill speech and language therapy staff vacancies and that all the panels involved were expiring. How did that come about? Do individuals who might have been on the panel...

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: That is fine, but what about the people who were on that panel and might have expected to get a placement or at least an offer at some point? Do they have to reapply? Is it thrown wide open again?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: Okay.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: Could Mr. Hennessy send me a note on that?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: Two people who were on that panel have contacted me to say they were surprised to see it expire and are wondering what the situation is. It would be helpful if the matter could be explained from the HSE's standpoint.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: I think it was a local panel.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: I think it was. I will be brief in asking my final question. Something that I should have asked Mr. O'Brien earlier has been niggling at me since I left. It might bring clarity to the issue I raised earlier. I refer to my opinion that there is a potential conflict with regard to conferences. Was the conference in question the only one attended by Mr. O'Brien that was paid for by a...

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: That was the only one.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: Fine. I think it is helpful to clarify that. Is attendance at such conferences something that occurs on a widespread basis in the higher echelons of the HSE organisation? Is it commonplace that people in the HSE would be catered for at conferences by private companies? Is it something extremely rare? Is it frowned upon? Is it commonplace?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: I know there have been changes there.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: I am not really talking about the doctors and the nurses. I am talking about HSE employees.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: I know that, but I am talking about HSE employees. There are six people from the HSE here today. How many of them have attended some of these educational conferences, or conferences by another name, down through the years? I refer to events paid for by private companies.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: That is not what I asked, in fairness. How many such trips have the witnesses gone on? How many of those trips would have been paid for by private companies?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: Okay. Anybody? Nobody. Mr. Mulvany?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: We probably should have asked it earlier. It clarifies the issue.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: It was best that I asked the question rather than leaving matters hanging.

Written Answers — Department of Foreign Affairs and Trade: Departmental Staff Allowances (3 Nov 2015)

John Deasy: 879. To ask the Minister for Foreign Affairs and Trade for details of the rent allowances paid to public servants and officials of his Department if placed on assignment in the United Kingdom and in mainland Europe; and the way in which these rates for living accommodation are calculated or benchmarked. [37900/15]

Finance Bill 2015: Second Stage (Resumed) (5 Nov 2015)

John Deasy: I would like to talk about the knowledge development box and the issues surrounding foreign direct investment. It is fair to say we needed to do something once the Government agreed to abolish the double Irish tax relief, which is being phased out over five years. The partial solution arrived at is the knowledge development box, otherwise called a patent box. It is nothing new. Other...

Finance Bill 2015: Second Stage (Resumed) (5 Nov 2015)

John Deasy: Three minutes.

Written Answers — Department of Justice and Equality: Crime Data (5 Nov 2015)

John Deasy: 155. To ask the Minister for Justice and Equality for an up-to-date breakdown of crime statistics in the Waterford and Kilkenny-Carlow Garda division, by category of offence; and by individual Garda district. [38917/15]

   Advanced search
Most relevant results are first | Show most recent results first | Show use by person

Search only John DeasySearch all speeches